DnB Asset Management AS Grows Stake in Danaher Co. (NYSE:DHR)

DnB Asset Management AS raised its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 2.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 174,467 shares of the conglomerate’s stock after purchasing an additional 3,566 shares during the period. DnB Asset Management AS’s holdings in Danaher were worth $40,049,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher during the 4th quarter worth about $31,000. Golden State Wealth Management LLC purchased a new stake in Danaher in the 4th quarter worth about $31,000. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher during the third quarter valued at approximately $39,000. Finally, Pineridge Advisors LLC grew its stake in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. The Goldman Sachs Group upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective for the company in a report on Friday, March 21st. Jefferies Financial Group dropped their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Robert W. Baird decreased their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, JPMorgan Chase & Co. dropped their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $278.24.

View Our Latest Research Report on Danaher

Danaher Trading Down 0.1 %

NYSE:DHR opened at $210.26 on Friday. The firm has a 50 day moving average of $215.23 and a 200 day moving average of $237.37. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The stock has a market capitalization of $150.27 billion, a price-to-earnings ratio of 39.82, a PEG ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business posted $2.09 earnings per share. As a group, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is presently 24.24%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.